Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Comparison of middle- and bottom-up mass spectrometry in forced degradation studies of bevacizumab and infliximab.
J Pharm Biomed Anal. 2023 Oct 25;235:115596. doi: 10.1016/j.jpba.2023.115596. Epub 2023 Jul 22.
J Pharm Biomed Anal. 2023.
PMID: 37540995
Review.
Forced Degradation Testing as Complementary Tool for Biosimilarity Assessment.
Dyck YFK, Rehm D, Joseph JF, Winkler K, Sandig V, Jabs W, Parr MK.
Dyck YFK, et al.
Bioengineering (Basel). 2019 Jul 21;6(3):62. doi: 10.3390/bioengineering6030062.
Bioengineering (Basel). 2019.
PMID: 31330921
Free PMC article.
Item in Clipboard
Cite
Cite